The KPNA3 Knockout A-549 Polyclonal Cells consist of a CRISPR/Cas9-edited polyclonal population in which the KPNA3 gene has been disrupted in A-549 lung adenocarcinoma epithelial cells. This mixed population carries heterogeneous gene edits, offering a loss-of-function model for studying KPNA3-dependent biology without the constraints of clonal isolation.
The A-549 host cell line, isolated from a 58-year-old Caucasian male with lung adenocarcinoma, is a widely used in vitro model for non-small cell lung cancer (NSCLC) and pulmonary epithelial barrier studies. These adherent cells retain key oncogenic signaling pathways and are extensively employed in cancer research, drug testing, and toxicology. Their established genetic background supports functional investigation of genes such as KPNA3 in lung adenocarcinoma pathogenesis.
KPNA3 encodes importin alpha-3, an adapter protein of the karyopherin alpha family that recognizes classical nuclear localization signals (cNLS) on cargo proteins. Importin alpha-3 recruits cargo and forms a complex with importin beta (KPNB1), which mediates docking to nuclear pore complexes via nucleoporins like NUP62 and NUP98. Nuclear translocation is driven by the RanGTP gradient. KPNA3 facilitates the nuclear import of transcription factors including NF-??B (p50/p65) and STAT1/2, thereby linking extracellular signals to gene expression. Upstream, KPNA3 is induced by interferon-alpha/gamma through JAK-STAT signaling and is regulated downstream of RAS/MAPK activation. It interacts with KPNB1 and various NLS-containing cargos, playing a critical role in nuclear transport of immune and cell cycle regulators.
In A-549 NSCLC cells, KPNA3 disruption impairs nuclear translocation of NF-??B and STATs, attenuating pro-inflammatory and survival gene programs. This is relevant to lung adenocarcinoma, where constitutive NF-??B activity and dysregulated nuclear transport contribute to tumor progression, chemoresistance, and immune evasion. Additionally, the importin pathway is exploited by respiratory viruses such as influenza A and SARS-CoV-2 for nuclear entry of viral components, making this knockout model a valuable system for studying host?Cvirus interactions in lung epithelium and identifying import-targeted antivirals.
These polyclonal knockout cells support diverse applications: western blotting and co-immunoprecipitation assess KPNA3?Ccargo complexes and phosphorylation; immunofluorescence quantifies NF-??B/STAT translocation; RT-qPCR and luciferase reporters measure transcriptional responses; flow cytometry enables cell cycle and apoptosis analyses; and viral infection assays combined with drug sensitivity screens facilitate antiviral and chemosensitizer discovery. High-throughput screening for import modulators is also feasible. For inquiries, contact Ascent Research.
